False-negative rates for MYC fluorescence in situ hybridization probes in B-cell neoplasms

Haematologica. 2019 Jun;104(6):e248-e251. doi: 10.3324/haematol.2018.207290. Epub 2018 Dec 6.

Affiliations

¹ Division of Hematopathology, Department of Laboratory Medicine and Pathology rebecca.king98@gmail.com.
² Division of Hematopathology, Department of Laboratory Medicine and Pathology.
³ Division of Laboratory Genetics, Department of Laboratory Medicine and Pathology.
⁴ Center for Individualized Medicine-Biomarker Discovery, Mayo Clinic, Rochester, MN, USA.

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Biomarkers, Tumor
DNA Probes*
False Negative Reactions
Gene Rearrangement
Genes, myc*
Humans
In Situ Hybridization, Fluorescence / methods
In Situ Hybridization, Fluorescence / standards*
Lymphoma, B-Cell / diagnosis*
Lymphoma, B-Cell / genetics*

Substances

Biomarkers, Tumor
DNA Probes